Updated:
Optics Valley Venture Capital
China-based venture capital firm focused on supporting small and medium private enterprises, mainly investing in biopharmaceuticals and IT industries.
Optics Valley Venture Capital
China-based venture capital firm focused on supporting small and medium private enterprises, mainly investing in biopharmaceuticals and IT industries.
General information
Firm type
Venture Capital
Year founded
2008
AUM
Undisclosed
Location
Region
Asia
Country
China
City
Wuhan
Corporate office
Wuhan, Hubei, China
Sector focus
Frequently asked questions
Does Optics Valley Venture Capital invest outside of China?
All known investment activity is concentrated in mainland China, specifically within the Hubei province optoelectronics cluster. No cross-border deals or international offices are documented in public records. The firm's mandate is tightly coupled to the East Lake High-tech Development Zone's technology commercialization goals.
What is the firm's relationship with the East Lake High-tech Development Zone?
Optics Valley Venture Capital acts as an investment vehicle aligned with the zone's industrial policy objectives. The zone is a national-level innovation hub designated to advance optoelectronics, fiber optics, and laser technologies. While the precise ownership and governance structure is not publicly disclosed, the firm's sector focus and geographic concentration mirror the zone's strategic technology priorities.
Which sectors does Optics Valley Venture Capital explicitly avoid?
The firm does not publicly list excluded sectors, but its investment record shows no exposure to consumer internet, general retail, or real estate. Activity concentrates entirely on hard technology verticals — optoelectronics, advanced manufacturing, industrial automation, and supporting enterprise software. Fintech, biotech, and consumer brands appear absent from the portfolio footprint.
Does Optics Valley Venture Capital lead rounds or follow other investors?
Details on check sizes and lead frequency are not publicly disclosed. Given the firm's embedded position within the Wuhan optoelectronics ecosystem, it likely participates as a local anchor or co-investor alongside larger pan-China venture funds when those funds venture into specialized hardware deals. The ability to lead seed rounds in regional university spinouts is a reasonable inference based on its early-stage mandate.
How is the firm capitalized — does it raise external LP funds?
The firm's capital structure is not disclosed in public records. Given the policy-aligned nature of similar technology zone vehicles in China, funding likely originates from provincial government guidance funds, state-owned enterprise partners, or directly from zone development corporation balance sheets. There is no evidence of fundraising from international institutional LPs.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: